“…Third, RAST testing also identifies when allergens differ greatly in their degree of sensitivity, so that these can be treated with different allergen doses in the preparation of immunotherapy treatment vials. 22 Less sensitive allergens are dosed at a high antigen concentration, whereas highly sensitive allergens are given at a dilute concentration, and this ability to tailor the antigen mix for multi-antigen treatment vials helps to reduce reactions caused by unanticipated high sensitivity antigens. Finally, use of the optimum dose, rather than the maximum tolerated dose, for maintenance immunotherapy significantly reduces the risk of maintenance dose reactions, since there is less chance of fluctuating environmental antigen levels adding to the slightly lower immunotherapy dose to exceed the symptom-producing threshold.…”